Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Biomarkers kunnen 'Lewy body'-dementie van Alzheimer onderscheiden
okt 2023 | Dementie